Rationale for the use of mitoxantrone in multiple sclerosis.
about
Mitoxantrone treatment in multiple sclerosis: a 5-year clinical and MRI follow-upA novel high throughput biochemical assay to evaluate the HuR protein-RNA complex formationBone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of SapacitabineCurrent role of chemotherapy and bone marrow transplantation in multiple sclerosis.Novel immunosuppressive therapy by M2000 in experimental multiple sclerosis.Induction of the ABC-transporters Mdr1/P-gp (Abcb1), mrpl (Abcc1), and bcrp (Abcg2) during establishment of multidrug resistance following exposure to mitoxantrone.Efficacy and safety of mitoxantrone use in primary and secondary progressive multiple sclerosis - study site experience based on the therapy of 104 patients.Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models.Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis.
P2860
Q28254413-27413AF3-6FD6-46C8-9A7F-A7A783D12DEEQ28535252-23EB8544-FE9D-4067-967E-BB5A965AF5B8Q36289307-C9E7FEFA-5E18-4F65-B64F-606E243875A2Q38268313-EBB1DC8E-CAD1-466C-8E81-CDE953B9647CQ40382676-DE9EA43C-D233-4D75-A8FD-550DA7D942CBQ40416245-E3EF4E9C-B09B-4E0D-B428-1CAA2B37D404Q40423250-463CF9DC-1497-4906-BD07-1238547D90FDQ46104696-206E575C-BFE9-4B03-B7FA-E1C38D4D802EQ46412279-0F7D711C-9FC1-4112-9D18-FAFCACBA2C6FQ48183791-E7C9E108-AA4F-4BF3-9EE0-64ABF0AF1CD6
P2860
Rationale for the use of mitoxantrone in multiple sclerosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Rationale for the use of mitoxantrone in multiple sclerosis.
@ast
Rationale for the use of mitoxantrone in multiple sclerosis.
@en
type
label
Rationale for the use of mitoxantrone in multiple sclerosis.
@ast
Rationale for the use of mitoxantrone in multiple sclerosis.
@en
prefLabel
Rationale for the use of mitoxantrone in multiple sclerosis.
@ast
Rationale for the use of mitoxantrone in multiple sclerosis.
@en
P2093
P1476
Rationale for the use of mitoxantrone in multiple sclerosis.
@en
P2093
Emmanuelle Le Page
Gilles Edan
Sean Morrissey
P356
10.1016/J.JNS.2004.04.017
P577
2004-08-01T00:00:00Z